Edgewise Therapeutics Management
Management criteria checks 4/4
Edgewise Therapeutics' CEO is Kevin Koch, appointed in Aug 2017, has a tenure of 6.75 years. total yearly compensation is $3.98M, comprised of 15% salary and 85% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth $6.58M. The average tenure of the management team and the board of directors is 3.7 years and 4.5 years respectively.
Key information
Kevin Koch
Chief executive officer
US$4.0m
Total compensation
| CEO salary percentage | 15.0% |
| CEO tenure | 6.8yrs |
| CEO ownership | 0.4% |
| Management average tenure | 3.7yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Edgewise Therapeutics: Behind The Massive Rally
Feb 18Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth
Dec 07
Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans
Aug 16Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth
Apr 28We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth
Jan 13Edgewise Therapeutics proposes $100M stock offering plan
Sep 13Edgewise Therapeutics GAAP EPS of -$0.32 beats by $0.02
Aug 04Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth
Aug 02We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely
Mar 24We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely
Nov 23Edgewise Therapeutics names new chief medical officer
Apr 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$4m | US$595k | -US$100m |
| Sep 30 2023 | n/a | n/a | -US$89m |
| Jun 30 2023 | n/a | n/a | -US$81m |
| Mar 31 2023 | n/a | n/a | -US$76m |
| Dec 31 2022 | US$5m | US$572k | -US$68m |
| Sep 30 2022 | n/a | n/a | -US$61m |
| Jun 30 2022 | n/a | n/a | -US$56m |
| Mar 31 2022 | n/a | n/a | -US$51m |
| Dec 31 2021 | US$5m | US$525k | -US$43m |
| Sep 30 2021 | n/a | n/a | -US$36m |
| Jun 30 2021 | n/a | n/a | -US$27m |
| Mar 31 2021 | n/a | n/a | -US$21m |
| Dec 31 2020 | US$2m | US$425k | -US$17m |
| Dec 31 2019 | US$741k | US$425k | -US$10m |
Compensation vs Market: Kevin's total compensation ($USD3.98M) is below average for companies of similar size in the US market ($USD5.72M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
CEO
Kevin Koch (63 yo)
6.8yrs
Tenure
US$3,975,855
Compensation
Dr. Kevin Koch, Ph.D. is a Venture Partner at OrbiMed Advisors, LLC. He has been a Member of Scientific Advisory Board at OnKure, Inc. Dr. Koch serves as a Member of Scientific Advisory Board at Frontier M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Independent Chairman | 7yrs | US$226.00k | 0% $ 0 | |
| President | 6.8yrs | US$3.98m | 0.37% $ 6.6m | |
| Co-Founder & Independent Director | 7yrs | US$193.00k | 0.021% $ 376.8k | |
| Chief Business Officer | 3.7yrs | US$1.76m | 0.011% $ 188.8k | |
| Chief Medical Officer | 3.1yrs | US$1.72m | 0.014% $ 250.2k | |
| Co-Founder | 6.9yrs | US$2.46m | 0.0039% $ 68.5k | |
| Chief Financial Officer | 3.7yrs | US$772.02k | 0.031% $ 551.7k | |
| General Counsel | 3.7yrs | no data | 0% $ 0 | |
| Chief Development Officer | 1.4yrs | no data | no data |
3.7yrs
Average Tenure
63yo
Average Age
Experienced Management: EWTX's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Independent Chairman | 7yrs | US$226.00k | 0% $ 0 | |
| President | 6.9yrs | US$3.98m | 0.37% $ 6.6m | |
| Co-Founder & Independent Director | 3.3yrs | US$193.00k | 0.021% $ 376.8k | |
| Co-Founder | 6.8yrs | US$2.46m | 0.0039% $ 68.5k | |
| Independent Director | 4.8yrs | US$199.50k | 0.017% $ 297.1k | |
| Independent Director | 3.4yrs | US$208.00k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.2yrs | US$485.00k | 0.012% $ 206.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | 4.3yrs | no data | no data |
4.5yrs
Average Tenure
63yo
Average Age
Experienced Board: EWTX's board of directors are considered experienced (4.5 years average tenure).